001     172104
005     20210129214357.0
024 7 _ |a 10.1111/febs.12800
|2 doi
024 7 _ |a 0014-2956
|2 ISSN
024 7 _ |a 1432-1033
|2 ISSN
024 7 _ |a 1742-464X
|2 ISSN
024 7 _ |a 1742-4658
|2 ISSN
024 7 _ |a WOS:000336451900014
|2 WOS
024 7 _ |a altmetric:2265035
|2 altmetric
024 7 _ |a pmid:24712547
|2 pmid
037 _ _ |a FZJ-2014-05647
041 _ _ |a English
082 _ _ |a 540
100 1 _ |a Bobby, Romel
|0 P:(DE-HGF)0
|b 0
245 _ _ |a Functional implications of large backbone amplitude motions of the glycoprotein 130-binding epitope of interleukin-6
260 _ _ |a Oxford [u.a.]
|c 2014
|b Wiley-Blackwell
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1415696391_4058
|2 PUB:(DE-HGF)
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|0 0
|2 EndNote
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a article
|2 DRIVER
520 _ _ |a Human interleukin (IL)-6 plays a pivotal role in the immune response, hematopoiesis, the acute-phase response, and inflammation. IL-6 has three distinct receptor epitopes, termed sites I, II, and III, that facilitate the formation of a signaling complex. IL-6 signals via a homodimer of glycoprotein 130 (gp130) after initially forming a heterodimer with the nonsignaling a-receptor [IL-6 a-receptor (IL-6R)] via site I. Here, we present the backbone dynamics of apo-IL-6 as determined by analysis of NMR relaxation data with the extended model-free formalism of Lipari and Szabo. To alleviate significant resonance overlap in the HSQC-type spectra, cell-free protein synthesis was used to selectively 15N-label residues, thereby ensuring a complete set of residue-specific dynamics. The calculated order parameters [square of the generalized model-free order parameter (S2)] showed significant conformational heterogeneity among clusters of residues in IL-6. In particular, the N-terminal region of the long AB-loop, which corresponds spatially to one of the gp130 receptor binding epitopes (i.e. site III), experiences substantial fluctuations along the conformation of the main chain (S2 = 0.3–0.8) that are not observed at the other two epitopes or in other cytokines. Thus, we postulate that dynamic properties of the AB-loop are responsible for inhibiting the interaction of IL-6 with gp130 in the absence of the IL-6R, and that binding of IL-6R at site I shifts the dynamic equilibrium to favor interaction with gp130 at site III. In addition, molecular dynamics simulations corroborated the NMR-derived dynamics, and showed that the BC-loop adopts different substates that possibly play a role in facilitating receptor assembly.
536 _ _ |a 453 - Physics of the Cell (POF2-453)
|0 G:(DE-HGF)POF2-453
|c POF2-453
|f POF II
|x 0
588 _ _ |a Dataset connected to CrossRef, juser.fz-juelich.de
700 1 _ |a Robustelli, Paul
|0 P:(DE-HGF)0
|b 1
700 1 _ |a Kralicek, Andrew V.
|0 P:(DE-HGF)0
|b 2
700 1 _ |a Mobli, Mehdi
|0 P:(DE-HGF)0
|b 3
700 1 _ |a King, Glenn F.
|0 P:(DE-HGF)0
|b 4
700 1 _ |a Grötzinger, Joachim
|0 P:(DE-HGF)0
|b 5
700 1 _ |a Dingley, Andrew J.
|0 P:(DE-HGF)0
|b 6
|e Corresponding Author
773 _ _ |a 10.1111/febs.12800
|g Vol. 281, no. 10, p. 2471 - 2483
|0 PERI:(DE-600)2172518-4
|n 10
|p 2471 - 2483
|t The @FEBS journal
|v 281
|y 2014
|x 1742-464X
856 4 _ |u http://onlinelibrary.wiley.com/doi/10.1111/febs.12800/pdf
856 4 _ |u https://juser.fz-juelich.de/record/172104/files/FZJ-2014-05647.pdf
|y Restricted
909 C O |o oai:juser.fz-juelich.de:172104
|p VDB
910 1 _ |a Forschungszentrum Jülich GmbH
|0 I:(DE-588b)5008462-8
|k FZJ
|b 6
|6 P:(DE-HGF)0
913 2 _ |a DE-HGF
|b POF III
|l Key Technologies
|1 G:(DE-HGF)POF3-550
|0 G:(DE-HGF)POF3-553
|2 G:(DE-HGF)POF3-500
|v BioSoft – Fundamentals for future Technologies in the fields of Soft Matter and Life Sciences
|x 0
913 1 _ |a DE-HGF
|b Schlüsseltechnologien
|1 G:(DE-HGF)POF2-450
|0 G:(DE-HGF)POF2-453
|2 G:(DE-HGF)POF2-400
|v Physics of the Cell
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF2
|l BioSoft
914 1 _ |y 2014
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
920 _ _ |l yes
920 1 _ |0 I:(DE-Juel1)ICS-6-20110106
|k ICS-6
|l Strukturbiochemie
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-Juel1)ICS-6-20110106
980 _ _ |a UNRESTRICTED
981 _ _ |a I:(DE-Juel1)IBI-7-20200312


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21